Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.
about
Immunologic aspect of ovarian cancer and p53 as tumor antigen.CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cellsSynthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cellsCD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationTargeted immunotherapy of cancer: development of antibody-induced cellular immunity.Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunitySome interfaces of dendritic cell biology.Helper T cells, dendritic cells and CTL Immunity.Antigen-presentation and the role of dendritic cells in periodontitis.Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection.Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance.Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells.The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulationCombinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination constructRegulatory roles for NKT cell ligands in environmentally induced autoimmunity.Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.TNF superfamily: costimulation and clinical applicationsImprovement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondiiEnhancement of proliferation and downregulation of TRAIL expression on CD8+ T cells by IL-21.The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Using monoclonal antibodies to stimulate antitumor cellular immunity.Murine and Human Model Systems for the Study of Dendritic Cell Immunobiology.Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells.Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis.Vaccines for established cancer: overcoming the challenges posed by immune evasion.Immune modulation by dendritic-cell-based cancer vaccines.Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation.
P2860
Q24814703-99BCF17D-A362-4316-A25B-8D1E4DBC9862Q28507848-7EBF06E4-D8B5-423A-B4B6-D38993BAAF9AQ30375348-1B5A9FCE-4E93-4D62-A72D-092587C07DFBQ33496761-05C092DB-CB7D-4A22-B778-52E8C02826F7Q34025520-ECA40C58-7315-47FD-B8B5-174524AD8EC7Q34119135-86C9AE37-BD31-4E87-B784-B9371CB9D404Q34382810-C3D9A66B-18DD-471D-BB19-B76A39074313Q34658452-79E35737-F7D6-44E0-9952-08349FE22890Q34678846-A17EE68B-C91C-4EFF-9A1C-B097D5B6238DQ34991001-A4BA129B-5473-4B02-AF59-2C12F6145184Q35084986-3C56E6FB-3BFC-4F66-8D24-BAE700E7E27EQ35139530-1FE51860-65E8-4C88-94E7-FD5B8C6B335DQ35219290-03324D30-E755-4897-81AC-D9A4F6D60A77Q35675903-D6CE3C27-3531-42A8-A624-D88FC647C404Q35755297-C0C8DFF2-85BB-4691-B49E-E63110B87103Q35849125-42A972F0-04F6-472F-B1DE-CD0EF9D9358DQ35994778-52E05043-70E5-4F70-8204-4703AA243DF0Q36043015-8EB75B78-E0A4-4F3A-B272-87A881594CBAQ36369913-9DF306A8-E5E2-415F-985F-85C639F9DBA1Q36371349-1C7458F5-E3DC-4985-8DF7-F690DD8B38C6Q36376315-B2CDB7E8-9DDB-48B6-9BF8-0B5C4414E099Q36402640-83B7E1DE-5C78-40D1-9588-D8564ECBDA24Q36422849-DC54F2BE-7045-4F3F-86B2-FE8C5A226F6CQ36616720-9187BBA3-197E-4897-BD5E-6F0F99531BFBQ36824687-14FFECA0-EB1C-4D63-8DAD-B93107970296Q37167857-2E30EC4E-CBCF-4567-913F-AA8895C2D96CQ37212043-36BF766F-A1CF-459D-9523-5473D8C26EFAQ37266849-286078D5-65E9-4799-9616-8CDE7B3ECE81Q37374700-2DF6CBA8-9414-4BA2-8788-D5718702E705Q37808395-EBDC979F-761D-48EA-821A-736CC66B8513Q37852758-94FD6CFB-9C97-4EE2-99F1-70F45BC085A1Q37909430-3A6C9B85-0D1E-4F87-8BBD-1A7223CFE435Q38247413-FDAB9225-F8F0-4376-BCEA-544CC3329150Q38437145-894C810E-FE54-487D-882D-E418D74EA8EDQ38474290-128B7E2D-3140-494F-8895-4F0A049CC57EQ38769021-142EF012-CADB-4786-AB58-499C7AD60CBEQ39147683-4A7B8265-F1A4-499F-9EA2-B5AC676C1F93Q39763286-92377312-7B1F-4CCA-A935-6CA9B388AAD8Q40054311-E33FA567-3AA8-4CB4-B277-FC9E2AC6B740Q40678768-6D6A0DDE-100A-47BB-8D87-C84BAD1FF0DF
P2860
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Immature dendritic cells acqui ...... pendent or -dependent stimuli.
@ast
Immature dendritic cells acqui ...... pendent or -dependent stimuli.
@en
type
label
Immature dendritic cells acqui ...... pendent or -dependent stimuli.
@ast
Immature dendritic cells acqui ...... pendent or -dependent stimuli.
@en
prefLabel
Immature dendritic cells acqui ...... pendent or -dependent stimuli.
@ast
Immature dendritic cells acqui ...... pendent or -dependent stimuli.
@en
P2093
P2860
P356
P1476
Immature dendritic cells acqui ...... ependent or -dependent stimuli
@en
P2093
C J Melief
D H Schuurhuis
E I van der Voort
F Ossendorp
M J Kleijmeer
P Ricciardi-Castagnoli
R Offringa
P2860
P304
P356
10.1084/JEM.192.1.145
P407
P577
2000-07-01T00:00:00Z